21 March 2019

Guangzhou Pharma eyes 65 bln yuan sales next year, paper says

Guangzhou Pharmaceutical Co. Ltd. (600332.CN) aims to achieve sales revenue of 65 billion yuan (US$10.67 billion) next year, bringing forward its 2015 sales target of 60 billion yuan under its original five-year plan, Shanghai Securities News reported Wednesday, citing chairman Li Chuyuan. The company will strive to achieve 100 billion yuan sales by 2016, Li was quoted as saying at the group’s seminar on strategic development. He said the company will invest 5 billion yuan to consolidate the nation’s medical resources and build a platform for the health sector through various means, including acquisitions, joint ventures, cooperation with other firms, and setting up new units, the report said.

– Contact HKEJ [email protected]



EJI Weekly Newsletter

Please click here to unsubscribe